GURUGRAM, India -
Sept. 15, 2025 -
PRLog -- The Saudi Arabia in-vitro diagnostics market was valued at USD 734.7 Million in 2024, and the market is predicted to reach USD 932.3 Million by 2030. The high burden of chronic diseases such as diabetes, cancer, cardiovascular diseases, and infectious diseases have led to considerable demand for in-vitro diagnostics in Saudi Arabia. Owing to the vast opportunities in this region, key players have been coming up with market development strategies to leverage it. For instance, in June 2021, G42 Healthcare and Seegene Inc. signed a Memorandum of Understanding (MoU) to offer fully equipped mobile diagnostics and testing laboratories across the Middle East and North African region, including Saudi Arabia. The growth is further supported by the government's plan to invest over USD 65 Billion to enhance healthcare infrastructure and privatize 290 hospitals and 2,300 primary health centers by 2030.
For more details, please visit: https://apeloconsulting.com/
product/saudi-
arabia-in-vitro-
diagnostics-
market-by-segment-
application-
product-end-
user-market-
share-key-company-
profiles-revenue-
recent-developments-
forecast-to-
2030/
Account Phone Number